Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-15

Clinical Trial Update: Efficacy of Cilostazol in Prevention of Peripheral Neuropathy [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update evaluates cilostazol for prevention of peripheral neuropathy in patients with breast cancer, spanning Phase 1 and Phase 2 and is marked …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cilostazol (Cilostazol)

Snippet

Sponsor: Mansoura University | Conditions: Peripheral Neuropathy, Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED